Strategy

Exploiting enzymes from the Arctic Ocean

Read more

Technology for direct cell reprogramming

Read more

Vivoryon Therapeutics tests Alzheimer's drug

Read more

Taking on the Alzheimer's conundrum

Read more

Revisiting antibody-drug conjugates

Read more

Why private equity is investing in biopharma

Read more

Dual inhibition of intracellular enzymes

Read more

The use of patient registries for regulatory purposes

Read more

Brain health and disease in the digital era

Read more

How bacteria evade treatment

Read more